StockDriftsStockDriftsTop 5 Finepoint Capital LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| QXO | QXO INC | 67.89% | 18.11M | $313.0M | +30.71%(+4.26M) | $36.73(-59.08%) | 2026-06-30 | |
| RXO | RXO INC | 32.05% | 5.36M | $147.8M | -46.84%(-4.72M) | $15.10(+50.45%) | 2026-06-30 | |
| ANNA | ALEANNA INC | 0.02% | 27.7K | $80K | +0.00%(+0) | $8.94(-71.16%) | 2026-06-30 | |
| MNYWW | MONEYHERO LIMITED | 0.01% | 895.0K | $37K | +0.00%(+0) | $0.10(-60.21%) | 2026-06-30 | |
| CLDI | CALIDI BIOTHERAPEUTICS INC | 0% | 1.0K | $177 | +0.00%(+0) | $2386.29(-99.93%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +19.49% | +70.59% | +10.34% | +63.58% |
| Top 20 Holdings Unweighted | -8.52% | -23.45% | -5.02% | -22.72% |
Finepoint Capital LP reports $2.80B in US-listed equity holdings across 6 positions in its most recent 13F filing. Its largest disclosed positions are QXO (67.9%), RXO (32.0%) and ANNA (0.0%). The top 20 holdings account for 99.97% of reported assets. Its disclosed equity book has returned +70.59% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Finepoint Capital LP, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Finepoint Capital LP’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1608126). View Finepoint Capital LP’s 13F filings on SEC